{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:18:45Z","timestamp":1772065125275,"version":"3.50.1"},"reference-count":57,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00124","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T22:59:05Z","timestamp":1467327545000},"page":"1159-1166","source":"Crossref","is-referenced-by-count":11,"title":["Is Coenzyme Q<sub>10<\/sub> Effective in Protection against Ulcerative Colitis? An Experimental Study in Rats"],"prefix":"10.1248","volume":"39","author":[{"given":"Mohamed Gamal","family":"Ewees","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basim Anwar Shehata","family":"Messiha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ahmed","family":"Abo-Saif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University"},{"name":"Department of Pharmacology, Faculty of Medicine, Al-Azhar University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hekma Abd El-Tawab","family":"Abd El-Latif","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Viscido A, Aratari A, Maccioni F, Signore A, Caprilli R. Inflammatory bowel diseases: clinical update of practical guidelines. Nucl. Med. Commun.<\/i>, 26<\/b>, 649\u2013655 (2005).","DOI":"10.1097\/01.mnm.0000169205.21377.6a"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ekbom A, Helmick C, Zack M, Adami HO, Zack M, Adami H-O. Ulcerative colitis and colorectal cancer: A population-based study. N. Engl. J. Med.<\/i>, 323<\/b>, 1228\u20131233 (1990).","DOI":"10.1056\/NEJM199011013231802"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jewell DP, Patel C. Immunology of inflammatory bowel disease. Scand. J. Gastroenterol.<\/i>, 20<\/b> (Suppl. 114), 119\u2013126 (1985).","DOI":"10.3109\/00365528509093772"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut<\/i>, 31<\/b>, 786\u2013790 (1990).","DOI":"10.1136\/gut.31.7.786"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M. Active oxygen species generated by monocytes and polymorphonuclear cells in patients in Crohn\u2019s disease. Dig. Dis. Sci.<\/i>, 33<\/b>, 951\u2013955 (1988).","DOI":"10.1007\/BF01535990"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kruidenier L, Verspaget HW. Oxidative stress as a pathogenic factor in inflammatory bowel disease\u2014radicals or ridiculous? Aliment. Pharmacol. Ther.<\/i>, 16<\/b>, 1997\u20132015 (2002).","DOI":"10.1046\/j.1365-2036.2002.01378.x"},{"key":"7","unstructured":"7) Michel C, Bernard C, Lahaye M. Algal oligosaccharides as functional foods: in vitro<\/i> study of their cellular and fermentative effects; Les oligosides algaux comme aliments fonctionnels: etude in vitro<\/i> de leurs effects cellularies et fermantaires. Sciences des Aliments<\/i>, 19<\/b>, 311\u2013332 (1999)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Son M, Ko JI, Kim WB, Kang HK, Kim BK. Taurine can ameliorate inflammatory bowel disease in rats. Adv. Exp. Med. Biol.<\/i>, 442<\/b>, 291\u2013298 (1998).","DOI":"10.1007\/978-1-4899-0117-0_37"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bhagavan HN, Chopra RK. Coenzyme q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res.<\/i>, 40<\/b>, 445\u2013453 (2006).","DOI":"10.1080\/10715760600617843"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fedacko J, Pella D, Fedackova E. Coenzyme Q10 in heart and brain diseases. Open. Nutra. J.<\/i>, 4<\/b>, 69\u201387 (2011).","DOI":"10.2174\/1876396001104010069"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP. Effect of coenzyme q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur. Heart J.<\/i>, 28<\/b>, 2249\u20132255 (2007).","DOI":"10.1093\/eurheartj\/ehm267"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D. Variable response to probiotics in two models of experimental colitis in rats. Crohn\u2019s & Colitis Foundation of America<\/i>, 8<\/b>, 399\u2013406 (2002).","DOI":"10.1097\/00054725-200211000-00004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mustafa A, El-Medany A, Hagar HH, El-Medany G. Ginkgo biloba<\/i> attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacological Research: Official J. Ital. Pharmacol. Soc.<\/i>, 53<\/b>, 324\u2013330 (2006).","DOI":"10.1016\/j.phrs.2005.12.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Karakaya K, Barut F, Hanci V, Can M, Comert M, Ucan HB, Cakmak GK, Irkorucu O, Tascilar O, Emre AU. Gastroprotective effects of CoQ10 on ethanol-induced acute gastric lesions. Bratisl Lek Listy<\/i>, 116<\/b>, 51\u201356 (2015).","DOI":"10.4149\/BLL_2015_010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Arafa HMM, Hemeida RA, El-Bahrawy AIM, Hamada FMA. Prophylactic role of curcumin in dextran sulphate sodium [DSS] induced ulcerative colitis murine model. Food Chem. Toxicol.<\/i>, 47<\/b>, 1311\u20131317 (2009).","DOI":"10.1016\/j.fct.2009.03.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Millar AD, Rampton DS, Chander CL, Claxson AWD, Blades S, Coumbe A, Panetta J, Morris CJ, Blake DR. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut<\/i>, 39<\/b>, 407\u2013415 (1996).","DOI":"10.1136\/gut.39.3.407"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurements of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol.<\/i>, 78<\/b>, 206\u2013209 (1982).","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Krawisz JE, Sharon P, Stenson F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology<\/i>, 87<\/b>, 1344\u20131350 (1984).","DOI":"10.1016\/0016-5085(84)90202-6"},{"key":"19","unstructured":"19) Zhou YH, Yu JP. Effects of Ginkgo biloba<\/i> extract on the antioxidation in rats with TNBS-induced colitis. Shijie Hua-ren Xiaohua Zazhi<\/i>, 15<\/b>, 1701\u20131705 (2007)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mart\u00edn MC, Martinez A, Mendoza JL, Taxonera C, D\u0131az-Rubio M, Fernandez-Arquero M, de la Concha EG, Urcelay E. Influence of the inducible nitric oxide synthase gene [NOS2A] on inflammatory bowel disease susceptibility. Immunogenetics<\/i>, 59<\/b>, 833\u2013837 (2007).","DOI":"10.1007\/s00251-007-0255-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Miranda KM, Espey MG, Wink DA. A rapid and simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide<\/i>, 5<\/b>, 62\u201371 (2001).","DOI":"10.1006\/niox.2000.0319"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem.<\/i>, 86<\/b>, 271\u2013278 (1978).","DOI":"10.1016\/0003-2697(78)90342-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sedlak J, Lindsay RH. Estimation of total, protein bond and non-protein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal. Biochem.<\/i>, 25<\/b>, 192\u2013205 (1968).","DOI":"10.1016\/0003-2697(68)90092-4"},{"key":"24","unstructured":"24) Claiborne A. Handbook of Methods for Oxygen Radical Research. Catalase activity.<\/i> (Greenwald RA ed.) Vol. 1, Boca Raton, pp. 283\u2013284 (1985)."},{"key":"25","unstructured":"25) Medhi B, Prakash A, Avti PK, Saikia UN, Pandhi P, Khanduja KL. Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats. Indian J. Exp. Biol.<\/i>, 46<\/b>, 583\u2013590 (2008)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods<\/i>, 50<\/b>, 81\u201392 (2004).","DOI":"10.1016\/j.vascn.2003.12.002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hajj Hussein IA, Tohme R, Barada K, Mostafa MH, Freund J-N, Jurjus RA, Karam W, Jurjus A. Inflammatory bowel disease in rats: bacterial and chemical interaction. World J. Gastroenterol.<\/i>, 14<\/b>, 4028\u20134039 (2008).","DOI":"10.3748\/wjg.14.4028"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Arafa HM, Hemeida RA, El-Bahrawy AI, Hamada FM. Prophylactic role of curcumin in dextran sulfate sodium [DSS]-induced ulcerative colitis murine model. Food Chem. Toxicol.<\/i>, 47<\/b>, 1311\u20131317 (2009).","DOI":"10.1016\/j.fct.2009.03.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Neurath MF, Fuss I, Kelsall BL, St\u00fcber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med.<\/i>, 182<\/b>, 1281\u20131290 (1995).","DOI":"10.1084\/jem.182.5.1281"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology<\/i>, 98<\/b>, 694\u2013702 (1990).","DOI":"10.1016\/0016-5085(90)90290-H"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med.<\/i>, 188<\/b>, 1929\u20131939 (1998).","DOI":"10.1084\/jem.188.10.1929"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Hoffmann JC, Pawlowski NN, K\u00fchl AA, H\u00f6hne W, Zeitz M. Animal models of inflammatory bowel disease: an overview. Pathobiology<\/i>, 70<\/b>, 121\u2013130 (2002\/2003).","DOI":"10.1159\/000068143"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Satoh H, Sato F, Takami K, Szabo S. New ulcerative colitis model induced by sulfhydryl blockers in rats and the effects of anti-inflammatory drugs on the colitis. Jpn. J. Pharmacol.<\/i>, 73<\/b>, 299\u2013309 (1997).","DOI":"10.1254\/jjp.73.299"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Rachmilewitz D, Okon E, Karmeli F. Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking crohn\u2019s disease. Gut<\/i>, 41<\/b>, 358\u2013365 (1997).","DOI":"10.1136\/gut.41.3.358"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tolstanova G, Deng X, French SW, Lungo W, Paunovic B, Khomenko T, Ahluwalia A, Kaplan T, Dacosta-Iyer M, Tarnawski A, Szabo S, Sandor Z. Early endothelial damage and increased colonic vascular permeability in the development of experimental ulcerative colitis in rats and mice. Lab. Invest.<\/i>, 92<\/b>, 9\u201321 (2012).","DOI":"10.1038\/labinvest.2011.122"},{"key":"36","unstructured":"36) Satok H, Szabo S. New animal model of ulcerative colitis induced by sulfhydryl blockers in rats. Gastroenterology<\/i>, 98<\/b>, 202 (1990)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Peppercorn MA, Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J. Pharmacol. Exp. Ther.<\/i>, 181<\/b>, 555\u2013562 (1972).","DOI":"10.1016\/S0022-3565(25)29238-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Hagar HH, El-Medany A, El-Eter E, Arafa M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur. J. Pharmacol.<\/i>, 554<\/b>, 69\u201377 (2007).","DOI":"10.1016\/j.ejphar.2006.09.066"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ballester I, Gonz\u00e1lez R, Nieto A, Zarzuelo A, de Medina FS. Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment. Life Sci.<\/i>, 76<\/b>, 2965\u20132980 (2005).","DOI":"10.1016\/j.lfs.2004.11.019"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Cestari SH, Bastos JK, Di Stasi LC. Intestinal anti-inflammatory activity of baccharis dracunculifolia in the trinitrobenzenesulphonic acid model of rat colitis. Evid. Based Complement Altern. Med.<\/i>, 2011<\/b>, 524349 (2011).","DOI":"10.1093\/ecam\/nep081"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Peppercorn MA. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new\u201d drug development. Ann. Intern. Med.<\/i>, 101<\/b>, 377\u2013386 (1984).","DOI":"10.7326\/0003-4819-101-3-377"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Plosker GL, Croom KF. Sulfasalazine. A review of its use in the management of rheumatoid arthritis. Drugs<\/i>, 65<\/b>, 1825\u20131849 (2005).","DOI":"10.2165\/00003495-200565130-00008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Das KM, Eastwood MA, McManus JPA, Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N. Engl. J. Med.<\/i>, 289<\/b>, 491\u2013495 (1973).","DOI":"10.1056\/NEJM197309062891001"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Dirlik M, Karahan A, Canbaz H, Caglikulekci M, Polat A, Tamer L, Aydin S. Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis. Curr. Therap. Res.<\/i>, 70<\/b>, 299\u2013315 (2009).","DOI":"10.1016\/j.curtheres.2009.08.005"},{"key":"45","unstructured":"45) Carlin G, Djurs\u00e4ter R, Goldschmidt T, Smedeg\u00e5rd G, Arfors KE. Inflammation. Basic Mechanisms, Tissue Injuring Principles, and Clinical Models. Degradation of hyaluronic acid and collagen by oxygen derived radicals.<\/i> (Venge P and Lindbom A ed.), Stockholm: Almqvist & Wiksell Int., pp. 297\u2013301 (1985)."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kruidenier L, Kuiper I, van Duijn W, Mieremet-Ooms MC, van Hogezand RA, Lamers CB, Verspaget HW. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J. Pathol.<\/i>, 201<\/b>, 17\u201327 (2003).","DOI":"10.1002\/path.1408"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Yamada T, Grisham MB. Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation. Klin. Wochenschr.<\/i>, 69<\/b>, 988\u2013994 (1991).","DOI":"10.1007\/BF01645144"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Belardinelli R, Mucaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme q10 and exercise training in chronic heart failure. Eur. Heart J.<\/i>, 27<\/b>, 2675\u20132681 (2006).","DOI":"10.1093\/eurheartj\/ehl158"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB. Coenzyme Q10<\/sub> and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann. Neurol.<\/i>, 36<\/b>, 882\u2013888 (1994).","DOI":"10.1002\/ana.410360613"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme q10 (co-Q10) in cardiac disease, hypertension and meniere-like syndrome. Pharmacol. Ther.<\/i>, 124<\/b>, 259\u2013268 (2009).","DOI":"10.1016\/j.pharmthera.2009.07.003"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Crane FL. Biochemical functions of coenzyme q10. J. Am. Coll. Nutr.<\/i>, 20<\/b>, 591\u2013598 (2001).","DOI":"10.1080\/07315724.2001.10719063"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion<\/i>, 7<\/b> (Suppl.), S41\u2013S50 (2007).","DOI":"10.1016\/j.mito.2007.02.006"},{"key":"53","unstructured":"53) Modi KP, Vishwakarma SL, Goyal RK, Bhatt PA. Beneficial effects of coenzyme Q10 in streptozotocin-induced type i diabetic rats. Iran. J. Pharmacol. Ther.<\/i>, 5<\/b>, 61\u201365 (2006)."},{"key":"54","unstructured":"54) Sawicka EWA, Ugosz AD, Rembacz KP, Guzik A. Drug biochemistry the effects of coenzyme q10 and baicalin in cisplatin-induced lipid peroxidation and nitrosative stress. Pol. Pharma. Soci.<\/i>, 70<\/b>, 977\u2013985 (2013)."},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Kagan T, Davis C, Lin L, Zakeri Z. Coenzyme q10 can in some circumstances block apoptosis, and this evect is mediated through mitochondria. Ann. N. Y. Acad. Sci.<\/i>, 887<\/b>, 31\u201347 (1999).","DOI":"10.1111\/j.1749-6632.1999.tb07920.x"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Sohet FM, Neyrinck AM, Pachikian BD, De Backer FC, Bindels LB, Niklowitz P, Menke T, Cani PD, Delzenne NM. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem. Pharmacol.<\/i>, 78<\/b>, 1391\u20131400 (2009).","DOI":"10.1016\/j.bcp.2009.07.008"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Jung HJ, Park EH, Lim CJ. Evaluation of anti-angiogenic, anti- inflammatory and antinociceptive activity of coenzyme Q[10] in experimental animals. J. Pharm. Pharmacol.<\/i>, 61<\/b>, 1391\u20131395 (2009).","DOI":"10.1211\/jpp.61.10.0017"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/7\/39_b16-00124\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:24:05Z","timestamp":1748993045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/7\/39_b16-00124\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00124","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}